Study to track benefits of compliance intervention.
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000523:psychology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D010349:Patient Compliance; D011788:Quality of Life; D019562:Viral Load
D017320:HIV Protease Inhibitors